TetraLogic Pharmaceuticals Corp (TLOG)
0.00
USD |
OTCM |
May 09, 16:00
TetraLogic Pharmaceuticals Cash from Financing (TTM): 0.00 for Sept. 30, 2016
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
September 30, 2016 | 0.00 |
June 30, 2016 | 2.586M |
March 31, 2016 | 2.587M |
December 31, 2015 | 1.790M |
September 30, 2015 | 1.823M |
June 30, 2015 | -0.763M |
Date | Value |
---|---|
March 31, 2015 | 43.46M |
December 31, 2014 | 44.35M |
September 30, 2014 | 99.70M |
June 30, 2014 | 99.71M |
March 31, 2014 | 63.56M |
December 31, 2013 | 63.46M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |
Theriva Biologics Inc | 0.625M |
Oragenics Inc | 0.2839M |